Tower Research Capital LLC (TRC) - CARDIFF ONCOLOGY INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$500
+49900.0%
360
-8.2%
0.00%
Q1 2023$1392
+22.5%
0.00%
Q4 2022$0
-100.0%
320
-17.5%
0.00%
Q2 2022$1,000
-98.3%
388
-98.4%
0.00%
-100.0%
Q1 2022$60,000
+233.3%
24,416
+715.2%
0.00%
Q4 2021$18,000
-78.0%
2,995
-75.4%
0.00%
-100.0%
Q3 2021$82,000
-34.9%
12,180
-36.0%
0.00%
-33.3%
Q2 2021$126,000
+12500.0%
19,017
+25256.0%
0.00%
Q4 2020$1,000
-98.0%
75
-97.9%
0.00%
-100.0%
Q3 2020$50,0003,5100.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$265,0000.37%
Artal Group S.A. 750,000$1,650,0000.09%
XTX Topco Ltd 55,081$121,0000.05%
GSA CAPITAL PARTNERS LLP 117,295$258,0000.04%
ELKHORN PARTNERS LIMITED PARTNERSHIP 23,800$52,0000.03%
Atom Investors LP 33,798$74,0000.03%
CHARTWELL INVESTMENT PARTNERS, LLC 296,507$652,0000.03%
Laurion Capital Management LP 722,100$1,589,0000.02%
MYDA Advisors LLC 30,000$66,0000.02%
Ergoteles LLC 184,000$405,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders